Skip to content
AnalystLens

Merck Annual Report (Amendment), Year Ended Dec 31, 1993

Filing Date
Filed June 16, 1994
Period End
December 31, 1993
Security
MRK
In the record · 2016–202610-K1210-Q338-K87

MRK filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 87 current reports (8-K) between 2016 and 2026.

  1. Impairment8-K · Feb ’17Feb ’17
  2. Restructuring8-K · Apr ’19Apr ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Restructuring8-K · Jul ’25Jul ’25

Summary

Summary of the 10-K/A filed June 16, 1994. Cited figures are marked; the original filing is the authoritative source.

This filing is not a Merck & Co. (MRK) 10-K.

It is Amendment No. 1 to Schering-Plough Corporation's Form 10-K for fiscal 1993, which adds the Form 11-K annual report for the Schering-Plough Employees' Savings Plan. Merck is not mentioned in the document. The analysis below covers the content actually provided, and it is of limited relevance to MRK investors.

It describes an employee benefit plan, not the company's operating or financial performance. The plan's net assets available for benefits rose 25.5% during 1993, from $93.5 million to $117.3 milliona. The increase was driven by $15.6 million in participant contributions and $11.6 million in investment earnings, offset by $3.3 million in distributions.

Approximately 8,870 employees participated at year-end 1993, up from 8,407 a year earlier. Participants could allocate contributions across eight investment funds. The Schering-Plough common stock fund, valued at $32.3 millionb, was the largest single holding at roughly 28% of plan assets.

Its net asset value per unit increased from $144.49 to $155.37c, about 7.5%. The Vanguard investment portfolios held $80.2 million, and participant loans totaled $4.8 million.

The plan's unallocated insurance contract matured on December 31, 1993, at an interest rate of about 8.23%d, and its funds were moved into Vanguard funds or the company stock fund. Deloitte & Touche issued an unqualified opinion dated June 7, 1994.

Key Highlights

  1. Document identity: this is Schering-Plough Corporation's 10-K/A (Amendment No. 1) adding the 11-K for its Employees' Savings Plan, not a Merck & Co. 10-K as the request states.
  2. Plan net assets grew 25.5% in 1993, from $93.5 million to $117.3 million, with a net increase of $23.9 million.
  3. Participant contributions totaled $15.6 million in 1993, and distributions to participants were $3.3 million.
  4. The Schering-Plough common stock fund held $32.3 million (about 28% of plan assets), and its unit value rose from $144.49 to $155.37 (about 7.5%).
  5. Participation grew to about 8,870 employees from 8,407, and the plan offered eight investment options, with Vanguard funds holding $80.2 million.
  6. Deloitte & Touche gave an unqualified audit opinion dated June 7, 1994, and the plan is IRS-qualified under Section 401(a).

Frequently Asked Questions

  1. Does this filing contain Merck & Co. (MRK) financial results?

    No. The filing belongs to Schering-Plough Corporation. It amends its 1993 Form 10-K to include the Form 11-K for the company's employee savings plan. It contains no Merck revenue, earnings, or pipeline information.

  2. How much did the Schering-Plough Employees' Savings Plan grow in 1993?

    Net assets available for benefits increased from $93.5 million at December 31, 1992, to $117.3 million at December 31, 1993. That is an increase of $23.9 million, or about 25.5%, driven mainly by employee contributions and investment earnings.

  3. How did the company stock fund perform?

    The Schering-Plough common stock fund's net asset value per unit rose from $144.49 to $155.37, about 7.5%. The fund held 207,886 units at year-end 1993, with a market value of $32.3 million.

  4. Are there any notable risks or changes in the plan?

    The plan's unallocated insurance contract, which earned about 8.23%, matured on December 31, 1993, and its funds were moved into Vanguard funds or the company stock fund. The company has not stated any intent to terminate the plan, though it has the right to do so under ERISA.